Trials / Completed
CompletedNCT07043465
Ambulant Monitoring to Detect Hemodynamic and Electrical Impact of Severe Tricuspid Valve Regurgitation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This exploratory study aims to study the feasibility to detect early signs of disease progression in patients with severe TVR (grade ≥3/4) by monitoring electrical cardiac activity and correlating it with echocardiographic findings. The Byteflies monitoring device will be used for continuous 14-day outpatient ECG tracking. Transthoracic echocardiography will assess structural and pressure changes in the heart and liver. The goal is to improve early detection of right heart failure and hepatic congestion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 14 days ambulatory rhythm monitoring | 14 days ambulatory rhythm monitoring using Byteflies |
Timeline
- Start date
- 2024-02-01
- Primary completion
- 2024-10-31
- Completion
- 2024-12-31
- First posted
- 2025-06-29
- Last updated
- 2025-06-29
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT07043465. Inclusion in this directory is not an endorsement.